Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118687852 | 11868785 | 2 | F | 20160827 | 20151225 | 20160901 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-14808505 | BRISTOL MYERS SQUIBB | 1.00 | DY | F | Y | 3.10000 | KG | 20160901 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118687852 | 11868785 | 1 | PS | STAVUDINE. | STAVUDINE | 1 | Transplacental | 80 MG, QD | U | 20412 | 80 | MG | QD | ||||||
| 118687852 | 11868785 | 2 | SS | NORVIR | RITONAVIR | 1 | Transplacental | 200 MG, QD | U | 0 | 200 | MG | QD | ||||||
| 118687852 | 11868785 | 3 | SS | ZIDOVUDINE. | ZIDOVUDINE | 1 | Transplacental | 1324 MG, QD | U | 0 | 1324 | MG | QD | ||||||
| 118687852 | 11868785 | 4 | SS | KALETRA | LOPINAVIRRITONAVIR | 1 | Transplacental | 1000 MG, UNK | U | 0 | 1000 | MG | |||||||
| 118687852 | 11868785 | 5 | SS | LAMIVUDINE. | LAMIVUDINE | 1 | Transplacental | 300 MG, QD | U | 0 | 300 | MG | QD | ||||||
| 118687852 | 11868785 | 6 | SS | INVIRASE | SAQUINAVIR MESYLATE | 1 | Transplacental | 2000 MG, QD | U | 0 | 2000 | MG | QD | ||||||
| 118687852 | 11868785 | 7 | SS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Transplacental | 500 MG, QD | U | 0 | 500 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118687852 | 11868785 | 1 | Product used for unknown indication |
| 118687852 | 11868785 | 2 | Product used for unknown indication |
| 118687852 | 11868785 | 3 | Product used for unknown indication |
| 118687852 | 11868785 | 4 | Product used for unknown indication |
| 118687852 | 11868785 | 5 | Product used for unknown indication |
| 118687852 | 11868785 | 6 | Product used for unknown indication |
| 118687852 | 11868785 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118687852 | 11868785 | OT |
| 118687852 | 11868785 | CA |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118687852 | 11868785 | Congenital anomaly | |
| 118687852 | 11868785 | Foetal exposure during pregnancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118687852 | 11868785 | 1 | 20070612 | 20070918 | 0 | |
| 118687852 | 11868785 | 2 | 20070918 | 20070927 | 0 | |
| 118687852 | 11868785 | 3 | 20071107 | 20071107 | 0 | |
| 118687852 | 11868785 | 4 | 20070612 | 20071107 | 0 | |
| 118687852 | 11868785 | 5 | 20070612 | 20070907 | 0 | |
| 118687852 | 11868785 | 6 | 20070918 | 20070927 | 0 | |
| 118687852 | 11868785 | 7 | 20070918 | 20071107 | 0 |